HTG Molecular Diagnostics Inc (HTGM)

NASDAQ
1.156
+0.026(+2.30%)
  • Volume:
    309,332
  • Day's Range:
    1.110 - 1.232
  • 52 wk Range:
    0.460 - 6.980
Earnings results expected today

HTGM Overview

Prev. Close
1.13
Day's Range
1.11-1.232
Revenue
8.65M
Open
1.13
52 wk Range
0.46-6.98
EPS
-2.53
Volume
309,332
Market Cap
12.81M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,721,886
P/E Ratio
-0.609
Beta
1.31
1-Year Change
-81.63%
Shares Outstanding
11,045,986
Next Earnings Date
Aug 11, 2022
What is your sentiment on HTG Molecular Diagnostics?
or
Vote to see community's results!

HTG Molecular Diagnostics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

HTG Molecular Diagnostics Inc Analysis

HTG Molecular Diagnostics Inc Company Profile

HTG Molecular Diagnostics Inc Company Profile

Employees
88

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyBuyNeutralSell
Technical IndicatorsStrong SellBuyNeutralStrong BuyStrong Sell
SummaryStrong SellBuyNeutralBuyStrong Sell
  • The company has recently announced the feasibility for a planned whole transcriptome panel, now the next phase is the optimization phase, and hopefully the product will be commercialized by the third quarter 2021. I am very optimistic about this stock!
    0
    • ertvery bad investment
      4
      • I will buy it...Sweet profits ahead
        1
        • Good luck. Any reason you are buying this? Or just hedging bets?
          0
        • I was wondering Did you get your sweet profit ? from feb till now? lol
          0
      • I will buy it...Sweet profits ahead
        0
        • buy?
          0
          • See you later.
            0